Leuprolide acetate 7.5mg; depot susp for IM inj; preservative-free. Store between 20° to 25°C (68° to 77°F); excursions permitted to 15°C to 30°C (59°F to86°F). Give as single IM inj into gluteal area ...
More than 10,000 adverse event reports complaining about the side effects of a commonly used drug called Lupron have been filed with the Food and Drug Administration, according to a recent report by ...
Leuprolide acetate 22.5mg; depot susp for IM inj; preservative-free. Store between 20° to 25°C (68° to 77°F); excursions permitted to 15°C to 30°C (59°F to86°F). Give as single IM inj into gluteal ...
Cipla is introducing leuprolide acetate injection depot, 22.5 mg, which is the generic of AbbVie’s Lupron Depot. It is indicated for palliative treatment of advanced prostate cancer. Leuprolide ...
Skillman, N.J.-based VGYAAN Pharmaceuticals has received regulatory approval for its fourth and fifth products. The Food and Drug Administration has approved the company’s generics of Tegretol ...
Dec. 29, 2004 -- The U.S. Food and Drug Administration (FDA) approved in October revisions to safety labeling to advise healthcare professionals of the following changes: leuprolide acetate is ...
Endometriosis is a common gynecological condition in which tissue similar to the tissue normally found lining the inside of the uterus is found on the outside of the uterus. This tissue outside the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results